The regulatory control of synthetic stimulants and psychoactive substances is a cornerstone of public health policy worldwide. Across major international regions—including the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland—governments maintain strict legislative boundaries to manage the risks associated with controlled substances. For individuals, researchers, and policymakers […]